Overall verdict
Neutral
5.0/10
1-year performance
+25.38%
Score breakdown
Up 25.4% over 1 year, 54% of the 52-week range.
Strongest: Financial strength 5.5/10. Weakest: Shareholder return 2.8/10.
16 analysts, target +0.4% vs the price.
KT&G Corporation, together with its subsidiaries, engages in the production, distribution, and sale of tobacco products in South Korea, Europe, and internationally. It provides reconstituent tobacco sheets, red ginseng, red ginseng products, other health foods, food and beverage products, health functional food products, and cosmetic and related products. The company also offers leaf tobacco cultivation support services; and develops, manufactures, and distributes drugs, bio-pharmaceuticals, over-the-counter medicines, and medical supplies and equipment.
In addition, it engages in the trading, real estate, leasing, and housing businesses. Further, the company engages in hotel development and management activities. The company was formerly known as Korea Tobacco and Ginseng Corporation and changed its name to KT&G Corporation in December 2002. KT&G Corporation was founded in 1987 and is headquartered in Daejeon, South Korea.
Sector
Consumer Staples
Industry
Tobacco
Primary listing
Krx
South Korea
CEO
Kyung-Man Bang
Founded
1987
Employees
4 331
Revenue / employee
1.5Md KRW
Next earnings
February 4, 2027 (estimated)
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
201000.00 KRW
52-week low
136600.00 KRW
1-year performance
25.38%
Rising
Year-to-date performance
20.62%
Rising
Drawdown
-14.73%
Mild pullback
Position in the 52-week range
54% of range
Range: 217000.00 KRW - 244978.49 KRW (2 methods agree)
The price implies growth of 22.71% per year; the company grows at 1.86%.
Gross margin 47.5%, net margin 16.0%, ROIC 10.3%, ROE 15.2%.
Net margin
15.96%
Fair
Sector 13.79%|S&P 13.40%
Gross margin
47.48%
High
Return on equity (ROE)
15.17%
Fair
Sector 14.71%|S&P 17.06%
Return on invested capital (ROIC)
10.27%
Fair
Free cash flow margin (FCF)
3.13%
Low
Profit-to-cash conversion (FCF conversion)
0.20x
Low
Margin stability
3.6 pts
Steady
Revenue to net income
Growth
3.9/10Revenue up 4.3% over 1 year, 5.4% a year over 5, EPS 1.9% a year over 5.
Revenue (trailing 12 months)
7.5T KRW
Revenue growth (1y)
4.28%
Solid
Revenue growth (3y)
12.45%
Moderate
EPS growth (1y)
-9.66%
Declining
EPS CAGR (5y)
1.86%
Low
EPS revisions (3 months)
-16.19%
Sharply revised down
Valuation
3.9/10P/E 12.4x, forward P/E 15.9x, EV/EBITDA 10.9x, PEG 6.69. The multiple sits in the 90th percentile of its own 5-year history.
P/E (TTM)
12.4x
Fair
Sector 14.8x|S&P 23.6x
Forward P/E
15.9x
Fair
EV / EBITDA
10.9x
Expensive
Sector 8.3x|S&P 15.5x
PEG
6.69
Very expensive
Sector 1.16|S&P 0.91
Fair value (reverse DCF)
240000.00 KRW
Deeply undervalued
P/E vs its own 5-year history
among the 10% highest valuations
At its historical high
Market cap
17.9T KRW
Financial strength
5.5/10Cash covers 82.9% of the debt, net debt/EBITDA 0.3x.
Net debt / EBITDA
0.3x
Stretched
Gearing (net debt / equity)
3.62%
Very solid
Cash
1.6T KRW
Cash / market cap
9.17%
Solid
Cash / total debt
82.90%
Very solid
Interest coverage
13.4x
Very solid
Net debt
338Md KRW
Equity
9.3T KRW
Closed daily candles, 2 years
Last close on November 11, 2026: 173,100.00 KRW
- MM20189,470.00
- MM50180,680.00
- MM200172,882.00
- RSI 1433.5
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+2.83%
200-day average slope, 3 months
+7.52%
50-day average slope, 1 month
+2.71%
Price structure
Lower lows
Bullish RSI divergence
No
20-day volatility
1.94 % per day
Volatility change
+5.42%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 10804.00 (14) | 10973.45 (14) | 6 974 329 (15) | 1 835 055 (15) | 1 089 763 (12) |
| 2027 | 13618.10 (14) | 13905.77 (15) | 7 307 852 (16) | 1 980 638 (16) | 1 403 425 (12) |
Amounts in millions of KRW, EPS in KRW per share. In brackets, the number of analysts. Consensus as of November 9, 2026.
Same sub-industry: 26 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HMSP | 6.7 | 7.4 | 4.1Md USD | 8.9x | 18.8 % | 7.8 % | 31.4 % | -0.4x | 13.4 % | -21.0 % | ||
| 2 | 2914 | 6.5 | 6.4 | 61.1Md USD | 17.2x | 15.9 % | 11.8 % | 10.7 % | 0.9x | 8.5 % | 5.8 % | ||
| 3 | IMB | 6.4 | 6.2 | 28.7Md USD | 13.7x | 9.0 % | 2.7 % | 13.4 % | 1.9x | 13.0 % | -9.9 % | ||
| 4 | MO | 6.2 | 6.3 | 129Md USD | 16.0x | 39.2 % | 3.6 % | 38.4 % | 1.4x | 7.0 % | 33.9 % | ||
| 5 | ITC | 6.1 | 6.0 | 37.2Md USD | 18.9x | 24.4 % | 3.9 % | 26.4 % | -0.8x | — | -29.8 % | ||
| 6 | PM | 5.8 | 4.4 | 306Md USD | 28.7x | 24.8 % | 5.2 % | 33.0 % | 2.3x | 4.4 % | 26.3 % | ||
| 7 | BATS | 5.3 | 4.3 | 129Md USD | 15.7x | 24.6 % | -1.0 % | 8.0 % | 2.5x | 5.5 % | 7.0 % | ||
| 8 | A033780 | 5.0 | 4.1 | 13.4Md USD | 12.4x | 16.0 % | 4.3 % | 10.3 % | 0.3x | 1.3 % | 25.4 % | ||
| 9 | 6969 | 3.6 | 2.5 | 6.5Md USD | 39.0x | 7.4 % | 20.9 % | 5.2 % | -6.4x | 1.1 % | -37.2 % |
